Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sahana Holla

Correction: Ac2PIM-Responsive miR-150 and miR-143 Target Receptor-Interacting Protein Kinase 2 and Transforming Growth Factor Beta-Activated Kinase 1 to Suppress NOD2-induced Immunomodulators.

Journal of Biological Chemistry

English

Related publications

665. miR-7 Inhibits Schwannoma Tumor Growth by Directly Targeting P21-Activated Kinase 1 and Epidermal Growth Factor Receptor

English

GβγSubunits Mediate Mitogen-Activated Protein Kinase Activation by the Tyrosine Kinase Insulin-Like Growth Factor 1 Receptor

Journal of Biological Chemistry

English

miR-199a Regulates the Tumor Suppressor Mitogen-Activated Protein Kinase Kinase Kinase 11 in Gastric Cancer

Biological and Pharmaceutical Bulletin

Medicine

Pharmacology

Pharmaceutical Science

2010

English

Transforming Growth Factor-Β-Activated Kinase 1 Resistance Limits Glucocorticoid Responsiveness to Toll-Like Receptor 4-Mediated Inflammation

English

Cocoa Polyphenols Suppress TNF-α-induced Vascular Endothelial Growth Factor Expression by Inhibiting Phosphoinositide 3-Kinase (PI3K) and Mitogen-Activated Protein Kinase Kinase-1 (MEK1) Activities in Mouse Epidermal Cells

British Journal of Nutrition

English

Transforming Growth Factor Beta-Activated Kinase 1 (TAK1)-dependent Checkpoint in the Survival of Dendritic Cells Promotes Immune Homeostasis and Function

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2012

English

miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer

PLoS ONE

Multidisciplinary

2015

English

Differential Roles of Checkpoint Kinase 1, Checkpoint Kinase 2, and Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Mediating DNA Damage-Induced Cell Cycle Arrest: Implications for Cancer Therapy

Molecular Cancer Therapeutics

Cancer Research

Oncology

2006

English

Differential Modulation of Mitogen-Activated Protein (MAP) Kinase/Extracellular Signal-Related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor Receptor

Journal of Biological Chemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sahana Holla

Correction: Ac2PIM-Responsive miR-150 and miR-143 Target Receptor-Interacting Protein Kinase 2 and Transforming Growth Factor Beta-Activated Kinase 1 to Suppress NOD2-induced Immunomodulators.

Related publications

665. miR-7 Inhibits Schwannoma Tumor Growth by Directly Targeting P21-Activated Kinase 1 and Epidermal Growth Factor Receptor

GβγSubunits Mediate Mitogen-Activated Protein Kinase Activation by the Tyrosine Kinase Insulin-Like Growth Factor 1 Receptor

miR-199a Regulates the Tumor Suppressor Mitogen-Activated Protein Kinase Kinase Kinase 11 in Gastric Cancer

Transforming Growth Factor-Β-Activated Kinase 1 Resistance Limits Glucocorticoid Responsiveness to Toll-Like Receptor 4-Mediated Inflammation

Cocoa Polyphenols Suppress TNF-α-induced Vascular Endothelial Growth Factor Expression by Inhibiting Phosphoinositide 3-Kinase (PI3K) and Mitogen-Activated Protein Kinase Kinase-1 (MEK1) Activities in Mouse Epidermal Cells

Transforming Growth Factor Beta-Activated Kinase 1 (TAK1)-dependent Checkpoint in the Survival of Dendritic Cells Promotes Immune Homeostasis and Function

miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer

Differential Roles of Checkpoint Kinase 1, Checkpoint Kinase 2, and Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Mediating DNA Damage-Induced Cell Cycle Arrest: Implications for Cancer Therapy

Differential Modulation of Mitogen-Activated Protein (MAP) Kinase/Extracellular Signal-Related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor Receptor